|Bid||0.00 x 1800|
|Ask||0.00 x 1800|
|Day's Range||35.67 - 36.58|
|52 Week Range||26.58 - 37.93|
|Beta (3Y Monthly)||0.19|
|PE Ratio (TTM)||20.83|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.31|
IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today the public offering of 15,000,000 shares of its common stock at a price of $35.00 per share in connection with its agreement to sell its common stock pursuant to the forward sale agreement described below. The underwriters have been granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock. BofA Securities and Morgan Stanley are acting as lead book-runners, and Barclays and Goldman Sachs are acting as additional book-runners for this offering.
IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below. The underwriters are expected to be granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock. BofA Securities and Morgan Stanley are acting as joint book-runners for this offering.
HCP, now renamed Healthpeak Properties, puts up an impressive show in third-quarter 2019 on the back of growth in the life-science and medical-office segments' net operating income.
HCP (HCP) delivered FFO and revenue surprises of 2.33% and 5.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif. , Oct. 30, 2019 /PRNewswire/ -- Healthpeak Properties, Inc., formerly known as HCP, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019 ), today announced results for ...
IRVINE, Calif., Oct. 30, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has changed its name to Healthpeak Properties, Inc. ("Healthpeak"), effective today. Healthpeak's common stock is expected to begin trading under its new name and ticker symbol "PEAK" on the New York Stock Exchange at the opening of trading on November 5, 2019. "Changing our name to Healthpeak Properties represents the culmination of efforts to reposition our strategy, team, portfolio and balance sheet," said Tom Herzog, Healthpeak's Chief Executive Officer.
Alexandria Real Estate Equities' (ARE) Q3 results reflect decent internal and external growth, as well as continued strong leasing activity and rental-rate growth in the quarter.
While HCP's Q3 results will likely reflect benefits of higher occupancy in the U.S. seniors housing market, a decline in income from direct financing lease might have impacted its revenue growth.
IRVINE, Calif. , Oct. 23, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share. The dividend will be ...
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]
It’s been a good year for real estate investments, but one Wall Street analyst said Tuesday that there’s even more upside ahead. The Analyst JPMorgan analyst Michael Mueller made the following adjustments ...
IRVINE, Calif. , Oct. 3, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) is scheduled to report its third quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, ...
HCP's mutually-beneficial agreement with Brookdale reduces the operator's concentration in the company's portfolio to 8% and enables transitions to Life Care Services under a highly-incentivized contract.
IRVINE, Calif. , Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that Fitch Ratings ("Fitch") upgraded HCP's corporate credit rating to BBB+ from BBB, with a stable outlook. ...
IRVINE, Calif., Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (HCP) today announced several transactions with Brookdale Senior Living Inc. ("Brookdale") related to HCP's 15-campus CCRC JV and triple-net portfolio with Brookdale that will position HCP to: (i) improve operator diversification, (ii) acquire Brookdale's interest in 12 CCRC campuses and (iii) strengthen the remaining Brookdale triple-net portfolio.
Moody's Investors Service ("Moody's") has assigned a Prime-2 (P-2) short-term rating to HCP, Inc's $1 billion senior unsecured commercial paper (CP) program in the U.S. Concurrently, Moody's also affirmed all existing ratings of HCP, including its Baa1 senior unsecured debt rating. HCP's P-2 short-term rating reflects the healthcare REIT's strong liquidity position supported by its large unsecured revolving credit facility with a total capacity of $2.5 billion. The CP notes will be issued by HCP, Inc. and rank pari-passu with the REIT's other unsecured senior debt.
IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the Commercial Paper Program, HCP may issue, from time to time, unsecured short-term debt securities with varying maturities not in excess of 397 days from the date of issue (the "Notes"). Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the maximum aggregate face or principal amount of Notes outstanding at any one time not exceeding $1.0 billion. The proceeds of the Notes will be used for general corporate purposes. HCP expects to use its revolving credit facility as a liquidity backstop for the repayment of the Notes issued under the Commercial Paper Program.
Delivering on its strategy to expand presence in the Boston region, HCP will acquire a trophy life science property -- 35 CambridgePark Drive -- for $332.5 million.
IRVINE, Calif., Sept. 9, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it executed a definitive agreement to acquire, for $332.5 million, a 224,000 square foot, LEED Gold® laboratory building located at 35 CambridgePark Drive, which is expected to close in December 2019. The property is being purchased from The Davis Companies and Invesco Real Estate ("Invesco"). 35 CambridgePark Drive is located in the Cambridge submarket of Boston, Massachusetts, adjacent to HCP's recently acquired property at 87 CambridgePark Drive and future development opportunity at 101 CambridgePark Drive. Combined, HCP has created up to 440,000 square feet of contiguous space across a modern campus.